Fig. 3
Kaplan Meier survival analysis of Ep-ICD in Oral Dysplasia and OSCC patients. a Dysplasia patients with increased overall (nuclear and cytoplasmic) Ep-ICD score had significantly reduced mean cancer free survival of 47 months as compared to patients with low overall Ep-ICD score (mean cancer free survival = 57.5 months; p = 0.044); b OSCC patients with increased Ep-ICDNuc and EpExMem score had significantly reduced mean disease free survival (DFS) of 33.7 months as compared to patients with decreased Ep-ICDNuc and EpExMem score (mean DFS = 46.3 months; p = 0.018)